NCT03136770View on ClinicalTrials.gov

A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

April 10, 2017

Study Completion Date

April 10, 2017

Conditions
Pharmacokinetics
Interventions
DIETARY_SUPPLEMENT

CK-30

Compound K 600 mg

DIETARY_SUPPLEMENT

Red ginseng extracts

Red ginseng extracts 2.94 g

Trial Locations (1)

110-744

Seoul National University Hospital Clinical Trials Center, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03136770 - A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K) | Biotech Hunter | Biotech Hunter